@article{8d420038d6a4429eb6cc2f9ba64a100c,
title = "First-in-man use of the MVAD axial-flow pump: Long-term outcome",
author = "Marian Urban and Anfrew Woods and Nicola Robinson-Smith and Guy MacGowan and Chandrika Roysam and Stephan Schueler",
note = "Funding Information: The authors thank the following investigators who participated in the European MVAD CE Mark Trial: Jens Garbade, Herzzentrum Leipzig GmbH, Germany; Paul Jansz, St. Vincent{\textquoteright}s Hospital Sydney, Australia; Thomas Krabatsch, Deutsches Herzzentrum Berlin, Germany; Pascal Leprince, Groupe hospitalier Piti{\'e}-Salp{\'e}tri{\`e}re, Paris, France; Artur Lichtenberg, Universit{\"a}tsklinikum D{\"u}sseldorf, Germany; Michiel Morshuis, Herz- und Diabeteszentrum Nordrhein Westfale, Bad Oeynhausen, Germany; Jan Schmitto, Medizinische Hochschule Hannover, Germany; Steven Tsui, Papworth Hospital NHS Foundation Trust, Cambridge, UK; Florian Wagner, Uniklinik Hamburg Eppendorf, Germany; Daniel Zimpfer, Medizinische Universit{\"a}t Wien, Austria. The MVAD Clinical Trial was sponsored by Medtronic (formerly HeartWare, Inc.).",
year = "2018",
month = jul,
doi = "10.1016/j.healun.2018.04.012",
language = "English (US)",
volume = "37",
pages = "933--936",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "7",
}